Responses of mice immunized with a DNA vaccine encoding carcinoembryonic antigen (CEA)

Vaccine

Volumn 24, Issue 21, 2006, Pages 4572-4575

  Johansson, Susanne ^a   Engström, Gunnel ^a   Winberg, Gösta ^a   Hinkula, Jorma ^a   Wahren, Britta ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cancer; CEA; DNA vaccine

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; DNA VACCINE; IMMUNOGLOBULIN G;

ARTICLE; CANCER; CELL SURFACE; DRUG DELIVERY SYSTEM; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL;

ANIMALS; CARCINOEMBRYONIC ANTIGEN; EPITOPES; KILLER CELLS, NATURAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, SCID; T-LYMPHOCYTES; TETANUS TOXOID; VACCINES, DNA;

EID: 33646832586     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.08.044     Document Type: Article

References (12)

1. Hammarström S. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Cancer Biol 9 (1999) 67-81
2. Saha A., Chatterjee S.K., Foon K.A., Primus J., Sreedharan S., Mohanty K., et al. Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice. Cancer Res 64 (2004) 4995-5003
3. Xiang R., Primus J., Ruehlmann J.M., Niethammer A.G., Silletti S., Lode H.N., et al. A dual-function DNA vaccine encoding carcinoembryonic antigen and CD40 ligand trimer induces T cell-mediated protective immunity against colon cancer in carcinoembryonic antigen-transgenic mice. J Immunol 167 (2001) 4560-4565
4. Liu M.A. DNA vaccines: a review. J Intern Med 253 (2003) 402-410
5. Conry R.M., White A., Fultz P.N., Khazaeli M.B., Strong T.V., Allen K.O., et al. Polynucleotide immunization of nonhuman primates against carcinoembryonic antigen. Clin Cancer Res 4 (1998) 2903-2912
6. Conry R.M., Curiel D.T., Strong T.V., Moore S.E., Allen K.O., Barlow D.L., et al. Safety and immunogenicity of a DNA vaccine encoding carcinoembryonic antigen and hepatitis B surface antigen in colorectal cancer patients. Clin Cancer Res 8 (2002) 2782-2787
7. Lund L.H., Andersson K., Zuber B., Karlsson A., Engström G., Hinkula J., et al. Signal sequence deletion and fusion to tetanus toxoid epitope augment antitumor immune responses to a human carcinoembryonic antigen (CEA) plasmid DNA vaccine in a murine test system. Cancer Gene Ther 10 (2003) 365-376
8. Rollman E., Hinkula J., Arteaga J., Zuber B., Kjerrström A., Liu M., et al. Multi-subtype gp160 DNA immunization induces broadly neutralizing anti-HIV antibodies. Gene Ther 11 14 (2004) 1146-1154
9. Samanci A., Yi Q., Fagerberg J., Strigård K., Smith G., Rudén U., et al. Pharmacological administration of granulocyte/macrophage-colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen. Cancer Immunol Immunother 47 (1998) 131-142
10. Engel A.M., Svane I.M., Rygaard J., and Werdelin O. MCA sarcomas induced in SCID mice are more immunogenic than MCA sarcoma induced in congenic, immunocompetent mice. Scand J Immunol 45 (1997) 463-470
11. Ullenhag G.J., Frodin J.E., Jeddi-Tehrani M., Strigard K., Eriksson E., Samanci A., et al. Durable carcinoembryonic antigen (CEA)-specific humoral and cellular immune responses in colorectal carcinoma patients vaccinated with recombinant CEA and granulocyte/macrophage colony-stimulating factor. Clin Cancer Res 10 (2004) 3273-3281
12. Nagorsen D., Keilholz U., Rivoltini L., Schmittel A., Letsch A., Asemissen A.M., et al. Natural T-cell response against MHC class I epitopes of epithelial cell adhesion molecule, her-2/neu, and carcionembryonic antigen in patients with colorectal cancer. Cancer Res 60 17 (2000) 4850-4854